BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36279855)

  • 1. Application of Circular RNA Circ_0071662 in the Diagnosis and Prognosis of Hepatocellular Carcinoma and Its Response to Radiotherapy.
    Wang X; Zhang J; Luo F; Shen Y
    Dig Dis; 2023; 41(3):431-438. PubMed ID: 36279855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
    Zhou C; Li R; Mi W
    Ann Clin Lab Sci; 2020 Nov; 50(6):734-738. PubMed ID: 33334787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma.
    Chen G; Xie D; Zhang P; Zhou H
    Bioengineered; 2022 Jun; 13(6):14118-14124. PubMed ID: 35730467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
    Li X; Yang J; Yang X; Cao T
    J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
    Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
    Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
    Qi SX; Sun H; Liu H; Yu J; Jiang ZY; Yan P
    World J Gastroenterol; 2019 Apr; 25(16):1964-1974. PubMed ID: 31086464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA 0068669 as a new biomarker for hepatocellular carcinoma metastasis.
    Yao T; Chen Q; Shao Z; Song Z; Fu L; Xiao B
    J Clin Lab Anal; 2018 Oct; 32(8):e22572. PubMed ID: 29785842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
    Zhang J; Chang Y; Xu L; Qin L
    J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0006091 as a novel biomarker for hepatocellular carcinoma.
    Zhang Y; Li J; Cui Q; Hu P; Hu S; Qian Y
    Bioengineered; 2022 Feb; 13(2):1988-2003. PubMed ID: 35068348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma.
    Zhu S; Chen Y; Ye H; Wang B; Lan X; Wang H; Ding S; He X
    Ann Hepatol; 2022; 27(2):100678. PubMed ID: 35093599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNAs hsa_circ_0001438 and hsa_circ_0000417 are downregulated and upregulated, respectively, in hepatocellular carcinoma.
    Imanishi S; Nagata S; Fujita T; Fujii H
    Int J Exp Pathol; 2022 Dec; 103(6):245-251. PubMed ID: 36153641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells.
    Zhao M; Dong G; Meng Q; Lin S; Li X
    J Cell Biochem; 2020 Nov; 121(11):4440-4449. PubMed ID: 32037619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of plasma exosomal
    Lyu L; Yang W; Yao J; Wang H; Zhu J; Jin A; Liu T; Wang B; Zhou J; Fan J; Yang X; Guo W
    Biomark Med; 2021 Apr; 15(5):359-371. PubMed ID: 33666515
    [No Abstract]   [Full Text] [Related]  

  • 16. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma.
    Jiang Z; Shen L; Wang S; Wu S; Hu Y; Guo J; Fu L
    Cancer Med; 2019 Dec; 8(17):7278-7287. PubMed ID: 31595711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global microarray profiling identified
    Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
    J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Zhang C; Zhang C; Lin J; Wang H
    Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.